Evaluates a novel sensor for urine refractive index detection, suggesting improved biomedical applications.
In this work, a defect-engineered one-dimensional photonic crystal (1D PhC) sensor is proposed for high-resolution urine refractive-index detection. The structure consists of alternating TiO₂/MgF₂ layers forming Bragg mirrors with a central urine-filled defect cavity, where a sharp localized resonance is generated inside the photonic band gap. Numerical analysis based on the transfer matrix method shows a stable red shift of the defect mode as the urine refractive index increases from 1.333 to 1.360. The proposed sensor achieves a sensitivity of 388.57 nm/RIU with excellent linearity \:(R²=0.999989) , together with an average FWHM of 0.0305 nm, an average Q-factor of \:2.55×\:10⁴, and an average FOM of \:1.32×\:10²RIU⁻¹ . A tolerance analysis under ± 2.5% thickness variation confirms that the resonance remains narrow and well defined, demonstrating good fabrication robustness. The results also highlight an important principle in photonic sensing: sensor performance should not be judged by sensitivity alone, but by a balanced combination of sensitivity, linewidth, resonance quality, figure of merit, and tolerance against structural deviations. These findings indicate that the proposed design is a promising candidate for practical urine-based biomedical sensing applications. A comparison with representative previously reported photonic-crystal sensing platforms further confirms the balanced overall performance of the proposed design.
No takes yet. Share an insight, caveat, or question.
Arafa H. Aly (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: